Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 306, pseudogene (RN7SL306P) is a human **pseudogene** that corresponds to a non-functional, typically non-expressed genomic DNA sequence related to the 7SL RNA gene. The true 7SL RNA is an essential component of the signal recognition particle (SRP), a ribonucleoprotein complex involved in targeting newly synthesized proteins to the endoplasmic reticulum[3][5]. However, like most 7SL pseudogenes, RN7SL306P is an **inactive genetic relic** formed by reverse transcription of RNA and reintegration into the genome, lacking evidence for functional RNA or protein product[1][2]. Pseudogenes in general may occasionally participate in regulatory functions, such as serving as decoys for microRNAs or RNA-binding proteins, but there is no evidence of any specific function, disease association, or druggability for RN7SL306P itself[1][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 306, pseudogene (RN7SL306P).